22-10-2024 |
PM |
|
DGX |
Quest Diagnostics Incorporated |
16,580 |
2.30 |
2.26 |
2.22 |
Quest Diagnostics Non-GAAP EPS of $2.30 beats by $0.04, revenue of $2.49B beats by $70M [10/22/2024 6:45 AM] |
157.51 |
10.14 (6.88%) |
150.01 |
2.64 (1.79%) |
120.87 - 159.36 |
1,706,988 |
690,000 |
1,929 |
|
|
23-07-2024 |
PM |
|
DGX |
Quest Diagnostics Incorporated |
16,310 |
2.35 |
2.31 |
2.30 |
Quest Diagnostics beats top-line and bottom-line estimates; raises FY24 revenue, EPS outlook [7/23/2024 6:48 AM] |
140.74 |
-6.61 (-4.49%) |
148.00 |
0.65 (0.44%) |
119.59 - 150.59 |
1,586,369 |
930,000 |
514 |
|
|
23-04-2024 |
PM |
|
DGX |
Quest Diagnostics Incorporated |
13,940 |
2.04 |
1.86 |
2.04 |
Quest Diagnostics beats Q1 top and bottom line estimates, raises FY outlook [4/23/2024 6:46 AM] |
136.44 |
6.35 (4.88%) |
133.20 |
3.11 (2.39%) |
119.59 - 148.62 |
1,669,966 |
950,000 |
8,223 |
|
|
01-02-2024 |
PM |
|
DGX |
Quest Diagnostics Incorporated |
14,540 |
2.15 |
2.14 |
1.98 |
Quest Diagnostics beats top-line and bottom-line estimates; initiates FY24 outlook [2/1/2024 6:47 AM] |
126.90 |
-1.53 (-1.19%) |
124.90 |
-3.53 (-2.75%) |
119.59 - 150.57 |
2,148,521 |
1,190,000 |
2,378 |
|
|
24-10-2023 |
PM |
|
DGX |
Quest Diagnostics Incorporated |
13,890 |
2.22 |
2.19 |
2.36 |
Quest Diagnostics Non-GAAP EPS of $2.22 beats by $0.03, revenue of $2.3B beats by $30M [10/24/2023 6:45 AM] |
123.72 |
2.27 (1.87%) |
124.00 |
2.55 (2.10%) |
119.59 - 158.34 |
1,300,569 |
940,000 |
455 |
|
|
26-07-2023 |
PM |
|
DGX |
Quest Diagnostics Incorporated |
16,130 |
2.30 |
2.23 |
2.36 |
Quest Diagnostics Non-GAAP EPS of $2.30 beats by $0.04, revenue of $2.34B beats by $90M [7/26/2023 6:47 AM] |
135.94 |
-8.98 (-6.20%) |
141.00 |
-3.92 (-2.70%) |
120.40 - 158.34 |
1,768,779 |
750,000 |
481 |
|
|
27-04-2023 |
PM |
6:45 AM ET (Apr 27) |
DGX |
Quest Diagnostics Incorporated |
16,390 |
2.04 |
1.97 |
3.22 |
Quest Diagnostics Non-GAAP EPS of $2.04 beats by $0.07, revenue of $2.33B beats by $130M [4/27/2023 6:47 AM] |
140.13 |
-6.71 (-4.57%) |
0.0 |
0.0 (0.00%) |
120.40 - 158.34 |
2,154,066 |
1,010,000 |
0 |
|
|
02-02-2023 |
PM |
6:45 AM ET (Feb 2) |
DGX |
Quest Diagnostics Incorporated |
16,600 |
1.98 |
1.89 |
3.33 |
Quest Diagnostics Non-GAAP EPS of $1.98 beats by $0.08, revenue of $2.33B beats by $70M [2/2/2023 6:50 AM] |
145.77 |
-2.87 (-1.93%) |
147.35 |
-1.29 (-0.87%) |
120.40 - 158.34 |
2,767,114 |
950,000 |
5,575 |
|
|
20-10-2022 |
PM |
6:45 AM ET (Oct 20) |
DGX |
Quest Diagnostics Incorporated |
15,110 |
2.36 |
2.15 |
3.96 |
Quest Diagnostics Non-GAAP EPS of $2.36 beats by $0.18, revenue of $2.49B beats by $150M, raises FY22 guidance [10/20/2022 6:46 AM] |
134.69 |
8.04 (6.34%) |
127.50 |
0.84 (0.66%) |
120.40 - 174.16 |
2,107,683 |
950,000 |
560 |
|
|
21-07-2022 |
PM |
6:45 AM ET (Jul 21) |
DGX |
Quest Diagnostics Incorporated |
15,690 |
2.36 |
2.15 |
3.18 |
Quest Diagnostics Non-GAAP EPS of $2.36 beats by $0.10, revenue of $2.45B beats by $110M, raises FY22 guidance [7/21/2022 6:46 AM] |
134.73 |
-0.11 (-0.08%) |
133.99 |
-0.85 (-0.63%) |
125.33 - 174.16 |
1,452,422 |
750,000 |
4,233 |
|
|
21-04-2022 |
PM |
6:40 AM ET (Apr 21) |
DGX |
Quest Diagnostics Incorporated |
15,920 |
3.22 |
2.91 |
3.76 |
Quest Diagnostics Non-GAAP EPS of $3.22 beats by $0.22, revenue of $2.61B misses by $30M, raises guidance [4/21/2022 6:46 AM] |
141.76 |
3.31 (2.39%) |
138.45 |
0.0 (0.00%) |
125.77 - 174.16 |
1,977,933 |
1,010,000 |
42,308 |
|
|
03-02-2022 |
PM |
6:45 AM ET (Feb 3) |
DGX |
Quest Diagnostics Incorporated |
16,560 |
3.33 |
3.29 |
4.48 |
Quest Diagnostics Non-GAAP EPS of $3.33 beats by $0.14, revenue of $2.74B beats by $80M [2/3/2022 6:41 AM] |
136.00 |
0.09 (0.07%) |
135.00 |
-0.91 (-0.67%) |
113.36 - 174.16 |
1,944,408 |
1,520,000 |
28,703 |
|
-
Quest Diagnostics Q4 2021 Earnings Preview [2/2/2022 2:52 PM]
-
Quest Diagnostics raises dividend by 6.5% to $0.66 [2/3/2022 6:43 AM]
-
Quest Diagnostics Non-GAAP EPS of $3.33 beats by $0.14, revenue of $2.74B beats by $80M [2/3/2022 6:41 AM]
-
Quest Diagnostics names new CEO; sets guidance in line with consensus [2/3/2022 8:42 AM]
-
FORTUNE Magazine Names Quest Diagnostics one of 2022 "World's Most Admired Companies" for Eighth Consecutive Year [Feb-02-22 04:19PM]
-
Is a Surprise Coming for Quest Diagnostics (DGX) This Earnings Season? [Feb-02-22 11:19AM]
-
Meridian Wealth Advisors, LLC Buys Vanguard S&P 500 ETF, Vanguard Mid-Cap ETF, JPMorgan ... [Feb-02-22 09:38AM]
-
QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2022; INCREASES QUARTERLY DIVIDEND 6.5% TO $0.66 PER SHARE [Feb-03-22 06:40AM]
-
Quest Diagnostics Announces Leadership Succession Plan [Feb-03-22 06:45AM]
-
Quest Diagnostics net income falls, but revenue beats analyst estimate [Feb-03-22 07:00AM]
-
Quest Diagnostics (DGX) Lags Q4 Earnings Estimates [Feb-03-22 07:55AM]
-
Quest Diagnostics (DGX) Q4 Revenues Top Estimates, Margins Down [Feb-03-22 09:36AM]
-
Valley Brook Capital Group, Inc. Buys Advanced Micro Devices Inc, Tesla Inc, DuPont de Nemours ... [Feb-03-22 01:38PM]
-
Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services [Feb-03-22 11:02AM]
-
FORTUNE Magazine Names Quest Diagnostics One of 2022 "World's Most Admired Companies" For Eighth Consecutive Year [Feb-03-22 02:55PM]
|
21-10-2021 |
PM |
6:45 AM ET (Oct 21) |
DGX |
Quest Diagnostics Incorporated |
17,560 |
3.96 |
2.94 |
4.31 |
Quest Diagnostics EPS beats by $0.90, beats on revenue, boost FY outlook [10/21/2021 6:46 AM] |
145.24 |
-1.61 (-1.10%) |
147.25 |
0.40 (0.27%) |
113.36 - 160.56 |
2,488,244 |
1,490,000 |
57,911 |
|
|
22-07-2021 |
PM |
6:45 AM ET (Jul 22) |
DGX |
Quest Diagnostics Incorporated |
16,570 |
3.18 |
2.87 |
1.42 |
Quest Diagnostics EPS beats by $0.32, beats on revenue [7/22/2021 6:47 AM] |
137.94 |
2.16 (1.59%) |
135.36 |
-0.42 (-0.31%) |
104.10 - 142.80 |
1,395,270 |
1,070,000 |
7,267 |
|
|
22-04-2021 |
PM |
6:45 AM ET (Apr 22) |
DGX |
Quest Diagnostics Incorporated |
17,200 |
3.76 |
3.77 |
0.94 |
Quest Diagnostics EPS beats by $0.02, beats on revenue [4/22/2021 6:46 AM] |
133.43 |
3.41 (2.62%) |
130.50 |
0.48 (0.37%) |
95.52 - 134.71 |
1,863,585 |
1,090,000 |
6,440 |
|
|
04-02-2021 |
PM |
6:45 AM ET (Feb 4) |
DGX |
Quest Diagnostics Incorporated |
17,650 |
4.48 |
4.29 |
1.67 |
Quest Diagnostics EPS beats by $0.24, beats on revenue [2/4/2021 6:52 AM] |
121.98 |
0.10 (-3.88%) |
127.00 |
0.10 (0.08%) |
73.02 - 134.71 |
2,027,790 |
1,397,425 |
20,286 |
|
|
22-10-2020 |
PM |
6:45 AM ET (Oct 22) |
DGX |
Quest Diagnostics Incorporated |
16,140 |
4.31 |
3.75 |
1.76 |
Quest Diagnostics EPS beats by $0.58, beats on revenue [10/22/2020 6:48 AM] |
126.20 |
3.37 (2.74%) |
123.75 |
0.92 (0.75%) |
73.02 - 131.81 |
1,549,740 |
933,539 |
44,999 |
|
|